Clinical Trial Technology Opportunity Assessment

A senior director in R&D at an F100 pharma company wanted to conduct a landscape analysis of technology trends and innovation impacting Phase 3 clinical trials in immunology to improve speed, effectiveness, and patient/provider experience.

BTG delivered a digital health strategy consultant with 20+ years of diverse strategic advisory, market access, and competitive intelligence experience. The consultant had previously spearheaded a range of initiatives for top biopharma companies to inform digital health and launch strategies. On this project, the consultant identified key players and areas of opportunity, anticipated disruptive competitor developments, and pinpointed ways to achieve competitive advantage. The output delivered by the talent served to inform the digital health strategy for the Immunology R&D team.

Previous Article
Decarbonization Strategy War-Gaming Exercise
Decarbonization Strategy War-Gaming Exercise

An F500 manufacturing company was watching decarbonization trends and wanted to better understand the evolv...

Next Article
Integrating a Siloed Supply Chain Function
Integrating a Siloed Supply Chain Function

A large footwear brand needed a supply chain expert to act as a thought partner, driving a project focused ...


Talk with BTG to learn more about our on-demand talent.

First Name
Last Name
I would like to receive the latest expert insights and news from Business Talent Group.
By registering, you agree to the processing of your personal data by Business Talent Group as described in the Privacy Statement.
View our Privacy Policy and Cookie Policy
Thank you! We will be in touch shortly.
Error - something went wrong!